[Form 4] Atlassian Corporation Insider Trading Activity
Rhea-AI Filing Summary
Michael Cannon-Brookes, listed as CEO, director and a 10% owner of Atlassian Corporation (TEAM), reported multiple sales of Class A common stock on 08/12/2025. The Form 4 shows seven separate dispositions totaling 7,665 shares, executed in multiple trades during the day under a Rule 10b5-1 trading plan adopted February 20, 2025. Weighted-average prices for the reported blocks are shown roughly in the $158–$164 range. Shares are held indirectly by CBC Co Pty Limited as trustee for the Cannon-Brookes Head Trust, and the last reported indirect beneficial ownership after these transactions is 260,610 shares. The form was signed by attorney-in-fact Veena Bhatia on 08/13/2025.
Positive
- Transactions were executed pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025, indicating pre-planned sales.
- Form shows clear disclosure of multiple trades, weighted-average prices, and indirect ownership via CBC Co Pty Limited as trustee.
- Form is signed by an attorney-in-fact (Veena Bhatia), indicating formal execution of the filing.
Negative
- Reported dispositions reduced indirect holdings to 260,610 shares after the last reported sale.
- Insider sales comprised 7,665 Class A shares on a single day (08/12/2025), which may be noted by investors despite being under a plan.
Insights
TL;DR: Insider sales of 7,665 TEAM shares were executed under a pre-established 10b5-1 plan; routine disclosure, limited immediate market impact.
The Form 4 documents seven dispositions by Michael Cannon-Brookes on 08/12/2025 totaling 7,665 Class A shares, with weighted-average prices reported per block between about $158 and $164. Transactions were executed pursuant to a Rule 10b5-1 plan adopted on February 20, 2025, and were processed in multiple trades during the day. Holdings are reported indirectly via CBC Co Pty Limited as trustee for the Cannon-Brookes Head Trust, with the last reported indirect ownership of 260,610 shares. From a market-impact perspective, these are disclosed, planned sales rather than ad hoc liquidations.
TL;DR: Proper governance procedures appear followed—sales under a 10b5-1 plan and form signed by attorney-in-fact—supporting compliance with disclosure rules.
The filing clearly states the trades were effected pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025, and includes footnotes describing execution in multiple trades and weighted-average prices. The disclosure identifies indirect beneficial ownership via a trustee and is signed by an attorney-in-fact, Veena Bhatia, on 08/13/2025. These elements indicate adherence to Section 16 reporting and 10b5-1 documentation requirements as presented in the form.